Evidence map›Paper›PMID 26750263›Full record

ArticleScientific reports2016

REPLACR-mutagenesis, a one-step method for site-directed mutagenesis by recombineering.

Ashutosh Trehan, Michał Kiełbus, Jakub Czapinski, Andrzej Stepulak, Ilpo Huhtaniemi, Adolfo Rivero-Müller

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. An Improved Vector System for Homogeneous and Stable Gene Regulation.International journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Journal of biological chemistry · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Ashutosh TrehanDepartment of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
Michał KiełbusDepartment of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
Jakub CzapinskiDepartment of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
Andrzej StepulakDepartment of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland.
Ilpo HuhtaniemiDepartment of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
Adolfo Rivero-MüllerDepartment of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
Medical University of Lublin · PLUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutagenesis is an important tool to study gene regulation, model disease-causing mutations and for functional characterisation of proteins. Most of the current methods for mutagenesis involve multiple step procedures. One of the most accurate methods for genetically altering DNA is recombineering, which uses bacteria expressing viral recombination proteins. Recently, the use of in vitro seamless assembly systems using purified enzymes for multiple-fragment cloning as well as mutagenesis is gaining ground. Although these in vitro isothermal reactions are useful when cloning multiple fragments, for site-directed mutagenesis it is unnecessary. Moreover, the use of purified enzymes in vitro is not only expensive but also more inaccurate than the high-fidelity recombination inside bacteria. Here we present a single-step method, named REPLACR-mutagenesis (Recombineering of Ends of linearised PLAsmids after PCR), for creating mutations (deletions, substitutions and additions) in plasmids by in vivo recombineering. REPLACR-mutagenesis only involves transformation of PCR products in bacteria expressing Red/ET recombineering proteins. Modifications in a variety of plasmids up to bacterial artificial chromosomes (BACs; 144 kb deletion) have been achieved by this method. The presented method is more robust, involves fewer steps and is cost-efficient.

Indexed as

Genetic EngineeringMutagenesis, Site-DirectedPlasmidsPolymerase Chain ReactionRecombination, GeneticChromosomes, Artificial, BacterialCloning, MolecularMutation

Identifiers

PMID26750263
PMCPMC4707547
OpenAlexW2396679263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.